Table 3.
Total N = 83 | |
---|---|
Jaundiced patient | 72 (86.7) |
CT/MRI/MRCP prior to biliary drainage, n (%) | 70 (84.3) |
Indications for biliary drainage, n (%) | |
Malignant hilar obstruction | 52 (62.7) |
Jaundice of unknown cause | 13 (15.7) |
Cholangitis | 6 (7.2) |
Increasing bilirubin | 5 (6.0) |
Suspicion of bile duct stones | 4 (4.8) |
Brush cytology | 3 (3.6) |
Technical success, n (%) | |
After initial procedure | 66 (79.5) |
After additional procedures (at regional center) | 69 (83.1) |
Therapeutic success if jaundiced (N = 74), n (%) | 37 (50.0) |
Number of drainage procedures, median (IQR) | 1 (2) |
>1 procedure, n (%) | 38 (45.8) |
>2 procedures, n (%) | 10 (12.0) |
Drainage method, n (%) | |
ERCP only | 67 (80.7) |
PTBD only | 2 (2.4) |
Both | 14 (16.9) |
Stent type (if technical success, N = 69), n (%) | |
Plastic | 64 (92.8) |
Metal | 5 (7.2) |
Stent position, n (%) | |
Left liver segments | 23 (27.7) |
Right liver segments | 29 (34.9) |
Left + right liver segments | 9 (10.8) |
Common bile duct only | 7 (8.4) |
Brush performed, n (%) | |
No | 34 (41.0) |
Yes (benign/inconclusive/malign) | 49 (59.0) (7/22/20) |
CT: computed tomography; MRI: magnetic resonance imaging; MRCP: magnetic resonance cholangiopancreatography; ERCP: endoscopic retrograde cholangiopancreatography; PTBD: percutaneous transhepatic biliary drainage.